Zhengye Biotechnology Holding (ZYBT) Construction in Progress (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Construction in Progress for 3 consecutive years, with $86005.5 the latest figure, recorded in Q4 2025.

• Quarterly Construction in Progress fell 93.67% year-over-year to $86005.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $86005.5 (down 93.67% YoY) and the FY2025 annual result came in at $87000.0, down 93.49% from the prior year.
• Construction in Progress fell to $86005.5 in Q4 2025 per ZYBT's latest filing, from $1.4 million in the prior quarter.
• Over the last five years, Construction in Progress for ZYBT reached as high as $1.4 million in Q4 2024 and fell as low as $86005.5 in Q4 2025.
• A 3-year average of $833801.2 and a median of $1.1 million in 2023 frame the typical range for Construction in Progress.
• Annual changes were most pronounced in 2024 — Construction in Progress advanced 28.35% — and 2025, when it slumped 93.67%.
• Year by year, Construction in Progress stood at $1.1 million in 2023, then climbed by 28.35% to $1.4 million in 2024, then sank by 93.67% to $86005.5 in 2025.
• According to Business Quant data, Construction in Progress over the past three periods registered $86005.5, $1.4 million, and $1.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.